Harmony Biosciences Holdings (HRMY) Non Operating Income (2019 - 2023)
Harmony Biosciences Holdings (HRMY) posted Non Operating Income of -$2.9 million for Q3 2023, down 4.68% sequentially from -$2.8 million in Q2 2023, and up 27.17% YoY from -$2.3 million in Q3 2022.
Harmony Biosciences Holdings (HRMY) Non Operating Income (2019 - 2023) Analysis & Trends
Harmony Biosciences Holdings has reported Non Operating Income for 5 years, with the latest figure at -$2.9 million in Q3 2023.
- Quarterly Non Operating Income rose 27.17% year-over-year to -$2.9 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$11.9 million (up 26.81% YoY) and the FY2022 annual result came in at -$15.7 million, up 34.63% from the prior year.
- Non Operating Income retreated to -$2.9 million in Q3 2023 per HRMY's latest filing, from -$2.8 million in the prior quarter.
- Over five years, Non Operating Income peaked at -$2.1 million in Q3 2019 and troughed at -$8.0 million in Q4 2020.
- A 5-year average of -$4.8 million and a median of -$4.2 million in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2020 and 2021: Non Operating Income tumbled 231.55% in 2020, then soared 47.44% in 2021.
- Over 5 years, Non Operating Income stood at -$2.7 million in 2019, then plunged by 189.99% to -$8.0 million in 2020, then jumped by 47.44% to -$4.2 million in 2021, then advanced by 14.43% to -$3.6 million in 2022, then rose by 18.89% to -$2.9 million in 2023.
- According to Business Quant data, Non Operating Income over the past three periods registered -$2.9 million, -$2.8 million, and -$2.6 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -2.91 Mn |
| Jun 30, 2023 | -2.78 Mn |
| Mar 31, 2023 | -2.65 Mn |
| Dec 31, 2022 | -3.58 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -3.93 Mn |
| Mar 31, 2022 | -4.17 Mn |
| Dec 31, 2021 | -4.19 Mn |
| Sep 30, 2021 | -5.43 Mn |
| Jun 30, 2021 | -7.23 Mn |
| Mar 31, 2021 | -7.13 Mn |
| Dec 31, 2020 | -7.97 Mn |
| Sep 30, 2020 | -6.95 Mn |
| Jun 30, 2020 | -6.94 Mn |
| Mar 31, 2020 | -6.37 Mn |
| Dec 31, 2019 | -2.75 Mn |
| Sep 30, 2019 | -2.10 Mn |